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Abstract We have investigated the cytotoxic and chemotactic 
potencies of malondialdehyde (MDA), hexanal, 4-hydroxyhex- 
enal (HHE), 4-hydroxynonenal (HNE) and 4-hydroxyoctenal 
(HOE), which are aldehydes found in oxidised low density 
lipoprotein (LDL), for human monocyte-macrophages. They 
were toxic in the following order: hexana l<HHE= 
HOE < HNE. HNE was toxic at 20 pM and chemotactic at 
2.5 p3Vl. The other aldehydes tested had no chemoattractant 
activity. Our results suggest that HNE arising from LDL 
oxidation could attract monocytes into the human atherosclerotic 
lesion. A direct cytotoxic role of aldehydes in foam cell death in 
the lesion is less likely. 
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1. Introduction 
Among the events of atherosclerosis that still remain unre- 
solved are the reasons for monocyte accumulat ion in the ar- 
tery wall leading to the formation of  the fatty streak and the 
cause of macrophage death that contr ibutes to the lipid core 
of the advanced lesion. The death of macrophage foam cells 
may be crucial for progression to the advanced lesion, which 
is responsible for clinical complications of myocardial and 
cerebral infarction [1]. 
Oxidation of LDL,  the physiologically most likely modifi- 
cation of LDL in vivo, is implicated in the progression of 
atherosclerotic lesions [2]. Quinn and co-workers have shown 
that oxidised LDL  induces chemotaxis in human monocytes, 
with lysophosphatidyl choline being one of its active compo- 
nents [3,4]. Further, oxidised LDL has been shown to be toxic 
for a variety of cell types including smooth muscle cells, fi- 
broblasts [5] and more recently mouse peritoneal macrophages 
[6,7], the macrophage-l ike cell line P388D1 [8] and human 
monocyte-macrophages [9]. However, oxidised LDL is a com- 
plex mixture of various components  including lipid hydroper- 
oxides, oxysterols and aldehydes [10]. Among the active prod- 
ucts of  LDL  oxidation the aldehydes have recently attracted 
special interest, for example as inducers of cytokine release 
[11] and markers of atherosclerosis [12]. Curzio et al. have 
extensively publ ished on the effect of  aldehydes on the motil- 
ity of rat neutrophils [13,14], but the possibility of their in- 
volvement in affecting monocyte migration, or macrophage 
death has not hitherto been investigated. 
*Corresponding author. Fax: (44) (1223) 333872. 
The aim of this study was to investigate the chemotactic 
activity and cytotoxic potencies of some of the aldehydes 
found in oxidised LDL for human monocyte-macrophages. 
2. Materials and methods 
All chemicals were purchased from Sigma Chemical Co. Ltd (Poole, 
Dorset, UK), unless otherwise indicated and were of the highest grade 
of purity available. 
The 4-hydroxyalkenals, 4-hydroxyhexenal (HHE), 4-hydroxyocte- 
nal (HOE) and 4-hydroxynonenal (HNE), were prepared as diethyl- 
acetals using an established method [15]. Prior to use, the acetals were 
converted to the free aldehydes by acid hydrolysis with 1 mM HC1 for 
1 h at room temperature. The exact concentrations of the aldehyde 
stock solutions (approximately 20 mM) were determined by measur- 
ing the UV spectrum (e223nm = 13750, 13800 and 13780 1 mo1-1 cm -1 
for HNE, HHE and HOE, respectively). The malondialdehyde 
(MDA) stock solution was prepared by incubating 1 M 1,1,3,3-tetra- 
methoxypropane in 1 mM HC1 for 1 h at room temperature. During 
acid hydrolysis the diethylacetal moiety is converted to two molecules 
of ethanol, resulting in a concentration of 40 mM (0.184%) in the 4- 
hydroxyalkenal stock solutions. In the MDA stock solution, methanol 
is formed during hydrolysis resulting in a concentration of 40 mM 
(0.128%) in 10 mM MDA. These concentrations of ethanol and 
methanol, even if undiluted, had no detectable effect on chemotaxis 
or cytotoxicity (the authors, unpublished observation). The MDA, 
HHE, HNE and HOE stock solutions were kept at 4°C and used 
within 7 days of preparation. Hexanal (Aldrich, Gillingham, Dorset, 
UK) was kept at room temperature. For the chemotaxis and cytotoxi- 
city experiments he aldehyde stock solutions were diluted in the re- 
spective assay medium to give the desired concentrations. 
Human monocyte-macrophages (HMM) were isolated from periph- 
eral blood from healthy volunteers as described previously [9]. Blood 
was diluted with phosphate-buffered saline (PBS) and layered onto 
Lymphoprep (Nycomed Pharma AS, Oslo, Norway). Following cen- 
trifugation at 300Xg, mixed mononuclear cells were removed from 
the interface. Following washing steps to remove platelets (PBS/cen- 
trifugation at 150Xg), cells were plated in 48-well plastic culture 
plates (Becton-Dickinson, New Jersey, USA) at a density of 3 x 106 
cells/ml in serum-free medium (Macrophage-SFM, Gibco, Paisley, 
Scotland, UK). After 1 h, non-adherent cells were removed, leaving 
adherent HMM. This technique gave HMM cultures of > 90% purity 
(based on Giemsa staining). 
Monocytes destined for use in the assessment of chemotaxis were 
obtained by centrifugation on a Percoll gradient [16]. Following the 
washing steps to remove the platelets (see above), the mixed mono- 
nuclear ceils were resuspended in 4 ml of PBS and mixed with 8 ml 
Percoll:Hank's balanced salt solution (6:1, pH 7.0) and spun for 30 
min at 400xg at room temperature. HMM were collected from the 
top of the gradient, washed once with PBS and used immediately. 
Chemotaxis was estimated in a 48-well Microchemotaxis Chamber 
(Neuro Probe Inc., Cabin John, MD, USA) using 5 ktm polyvinylpyr- 
rolidone-free polycarbonate filters [17]. Dilutions of potential che- 
moattractant and cell suspensions (106 cells/ml) were prepared in 
RPMI 1640 supplemented with 0.25% fatty acid-free BSA. 30 ~tl/ 
well of medium control or potential chemoattractant was applied to 
the bottom plate and after insertion of the filter, 50 I.tl/well cell sus- 
pension was put in the upper plate. After incubation at 37°C for 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
P I IS0014-5793(96)00559-5  
166 K. Miiller et al./FEBS Letters 388 (1996) 165-168 
"X'e"~ 
6 
E 
(D 
2 
• 1(- ,.~ 
• K'- ,K.. I(-  
...T--, 
- -  I -I(- -](- 
0 I i i I I i i 
m HNE (pM) 
×1 
×1 
x~ 
x[  
Xl 
x l  
"11")1" ~XI  
I 
fMLP 
O 
O 
Fig. 1. Chemotactic activity of HNE. Human monocyte-macro- 
phages were assessed for chemotaxis in response to 0.625-200 gM 
HNE. fMLP (10 nM) was employed as a positive control. Cells in- 
cubated in the absence of aldehydes are denoted by no additions 
(NA). The results shown are the mean chemotactic ndices + S.D. of 
one experiment carried out in triplicate which was representative of 
three. Statistically significant differences from the no additions con- 
trol are denoted by: *P <- 0.1, **P <- 0.01 and ***P -< 0.001. 
90 min, the filter was removed and stained with Diff-Quik (Browne 
Ltd, Reading, Berkshire, UK). Then, non-migrated cells were wiped 
off the top side, and the filter was mounted on a glass slide using oil. 
All samples were tested in triplicate. To assess chemotaxis, migrated 
cells in 4 high power fields (HPFs, magnification x 400) were counted 
for each well. Results are given as the chemotactic ndex (CI), = the 
ratio of cells in 4 HPFs with chemoattractant to cells in 4 HPFs in 
medium without chemoattractant. Inhibition of random migration 
was assessed as the decrease of migrated cells with sample solution 
as compared to the medium control (50% inhibition = chemotactic 
index of 0.5). 
For the measurement of cytotoxicity HMM were preloaded with 
tritiated adenine (Amersham Radiochemicals, Amersham, Bucks, UK, 
24 Ci/mmol) for 1 h (0.5 IxCi/well) using an established technique [9]. 
After washing with PBS, cells were incubated in Macrophage-SFM in
the presence or absence of the various aldehydes. After the appropri- 
ate incubation, samples of medium (200 IJ.1) were counted using a 
liquid scintillation counter and OptiPhase 'HiSafe' scintillant (Fisons 
Scientific Equipment, Loughborough, Leicestershire, UK). Intracellu- 
lar radioactivity was determined by lysing the cells with 1%,, (v/v) 
Triton X-100, followed by liquid scintillation counting. The percen- 
tage of total radioactivity leakage into the medium was calculated. 
The statistical significance of the data was determined, where ap- 
propriate, using unpaired Students' t-tests either alone, or in combi- 
nation with Analysis of Variance (ANOVA) using Microsoft Excel 
software for Microsoft Windows 3.1. 
concentrations of 1.25 and 2.5 laM with a maximum at 2.5 
laM (4.7 + 2.9, mean chemotactic index + S.D. of three sepa- 
rate experiments). On average the maximal chemotactic activ- 
ity of HNE was slightly lower than that of 10 nM fMLP 
(chemotactic index of 6.0 + 1.8). Occasional preparations of 
monocytes, however, showed no response to HNE. 
Concentrations in the range of 0.1 laM up to 100 mM, for 
MDA,  hexanal, HHE,  HNE and HOE, were examined for a 
possible inhibitory effect on random cell migration, i.e. cells 
migrating spontaneously in the absence of chemoattractant. 
Below, the aldehydes are arranged in ascending order of in- 
hibitory potency. Figures in parentheses are the concentra- 
tions required to inhibit random migration by 50%. Hexanal 
(22 mM)<MDA (3 mM)<HHE (90 laM)<HOE (80 
laM) < HNE (18 laM). 
Hexanal was not toxic at concentrations up to and includ- 
ing 800 laM, as determined by the tritiated adenine method. 
Statistically significant leakage of radiolabel was obtained at 8 
and 80 mM, but this effect is of dubious biological relevance 
(Fig. 2A). Menadione, a lipophilic quinone which possesses 
both redox cycling and arylating activity, induces oxidative 
stress and is cytotoxic and was included as a positive control 
at 200 mM. It induced significant oxicity after 2 h, and by 6 h 
leakage of radioactivity was near-total (data not shown). The 
extent of leakage of radioactivity from no addition controls 
also increased with time over the 24 h period investigated 
(Fig. 2A). Exposure to MDA induced leakage at 1 mM. Con- 
centrations below 1 mM were not toxic at any time. Exposure 
of cells to 8 and 16 laM MDA produced an extent of leakage 
which was not significantly different from no addition controls 
up to and including 24 h (Fig. 2B). The leakage of radioac- 
tivity from cells resulting from exposure to concentrations of 
HNE of 20 gM was significantly different from no addition 
controls and was near-total at 24 h (Fig. 2C). HHE also ex- 
hibited significant oxicity (Fig. 2D) at concentrations of 50 
laM and above. HOE produced concentration-dependent toxi- 
city at 24 h. Marked toxicity was observed at 6 h with 200 gM 
HOE. Significantly increased leakage compared with no addi- 
tion controls was obtained with 100 gM HOE (Fig. 2E). It 
can be seen from the data in Fig. 1 that the aldehydes howed 
an ascending order of toxicity: hexanal < HHE = 
HOE< HNE. The use of two other cytotoxicity assays 
(MTT dye reduction, a measure of mitochondrial integrity, 
and neutral red staining, a measure of cell adherence) con- 
firmed the results obtained with tritiated adenine (data not 
shown). 
3. Results 
The ability of MDA,  hexanal, HHE,  HNE and HOE to 
attract HMM was compared with N-formyl-leucine-methio- 
nine-phenylalanine (fMLP) at 10 nM, as a positive control. 
Since many chemoattractants induce chemotaxis only around 
an optimal concentration, the aldehydes were tested over a 
wide concentration range, initially. MDA,  hexanal and 
HHE (10 -3 M to 10 -16 M) and HOE (10 -5 M to 10 -18 M) 
did not induce chemotaxis in HMM at any of the concentra- 
tions tested (data not shown). In contrast, HNE elicited chem- 
otaxis (Fig. 1) and a narrower concentration range (0.625 laM 
to 200 laM) was examined to assess the optimal concentration. 
Significant chemotactic activity with HNE was observed at 
4. Discussion 
In the present study five aldehydes which can be found in 
oxidised LDL were examined for their chemotactic and cyto- 
toxic potencies for human monocyte-macrophages. The issue 
we were attempting to address was whether these aldehydes 
could contribute to the recruitment or the death of macro- 
phages, in vitro, at concentrations actually present in oxidised 
LDL. 
The composition of oxidised LDL varies strongly with oxi- 
dation conditions and also somewhat with individual batches 
of the native LDL from which it is prepared. Published data 
of aldehyde concentrations in strongly oxidised LDL (55 lag 
protein/ml with 1.66 laM Cu 2+ for 24 h, leading to complete 
consumption of polyunsaturated fatty acids) give the follow- 
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Fig. 2. Cytotoxicity of aldehydes. Human monocyte-macrophages were preloaded with tritiated adenine and then exposed to hexanal (A), 
MDA (B), HNE (C), HHE (D) and HOE (E), for up to 24 h. Results hown are the mean percentage of total radioactivity leakage into the 
medium + S.D. for triplicate wells from one experiment typical of three. Statistically significant differences from the no addition controls (NA) 
are indicated by: *P-<-0.1, **P -< 0.01, ***P -< 0.001. 
ing levels for hexanal, MDA, HNE, and HHE: 229, 114, 114 
and 49 nmol/mg LDL protein [10,18]. 
In previous tudies with human monocyte-macrophages, w  
obtained reproducible cell-killing with copper-oxidised LDL 
at a concentration f 200 ~tg/ml in culture medium [9]. Anal- 
ysis of this less extensively oxidised LDL (1 mg protein/ml 
using 5 p.M Cu 2+ for 24 h, resulting in consumption of ap- 
proximately 70% of the polyunsaturated fatty acids) using the 
same analytical method as Esterbauer and colleagues indi- 
cated concentrations of hexanal, HNE and HHE as 71, 22 
and 4 nmol/mg LDL protein (unpublished data). Extrapolat- 
ing from these data, we suggest hat the final concentrations 
of aldehydes in our previous cultures exposed to oxidised 
LDL were: hexanal 14 I.tM, MDA ,~ 17 I.tM, HNE 4.4 ~tM, 
HHE 0.8 I.tM and HOE ,~ 1 ~tM. Taken together with the 
results of this study, it appears unlikely that any of these 
aldehydes alone could account for the observed cytotoxicity 
of oxidised LDL for HMM. However, the combined effect of 
the various aldehydes might be greater and result in increased 
toxicity, and toxicity of oxidised LDL will also depend on 
oxidation conditions. Furthermore, hexanal, HNE and HHE 
are lipophilic compounds and remain largely associated with 
the LDL particle [19]. 'Local' concentrations of these alde- 
hydes in the lipid phase of oxidised LDL would therefore be 
much higher and have been estimated to be ,~ 300 mM for 
hexanal and ,~ 150 mM for HNE in strongly oxidised LDL 
[10]. Also, oxidised LDL contains lipid hydroperoxides which 
are potentially able to decompose to generate aldehydes in 
situ. The modification of membrane proteins for example by 
these aldehydes might then result in damage to the cell. HNE 
was shown to bind to Na+-K+-ATPase in vitro, leading to a 
loss in enzyme activity [20]. Furthermore, HNE binds to 
apoB-100 to give a form of LDL avidly phagocytosed by 
mouse peritoneal macrophages resulting in intracellular lipid 
accumulation [21,22]. In addition to aldehydes, oxidised LDL 
contains other cytotoxic components, e.g. lipid hydroperox- 
ides and oxysterols [23,24]. Thus toxicity of oxidised LDL 
could arise from the combined effect of these and other as 
yet unidentified cytotoxins. 
Previously, strongly oxidised LDL was shown to induce 
chemotaxis in human monocytes at a concentration of 100 
gg/ml, with lysophosphatidyl choline being one of its active 
components. A synthetic lysophosphatidyl choline, 1-palmi- 
toyl-lysophosphatidyl choline, had comparable chemotactic 
activity with an optimum concentration at 25 txM [3,4]. Our 
experiments demonstrate hat HNE is a strong chemoattrac- 
tant for human monocytes at concentrations which can be 
found in oxidised LDL. With an optimum at 2.5 I.tM, HNE 
was about ten-fold more effective on a molar basis than 1- 
palmitoyl-lysophosphatidyl choline. HNE could, therefore, 
contribute significantly to the chemotactic activity of oxidised 
LDL observed in vitro. Curzio and colleagues howed that 
HNE elicits chemotaxis in rat pleural neutrophils at similar 
concentrations (3.7-8.4 ktM), but the number of neutrophils 
responding to HNE was only about 50% of that for fMLP 
and occasional preparations of neutrophils howed no re- 
sponse at all [25,26]. It was suggested that either only a certain 
subpopulation of neutrophils react to HNE, or that the neu- 
trophils, which were derived from pleural exudate, had been 
desensitized by previous exposure to HNE in vivo. Indeed, 
HNE was demonstrated to act as a chemoattractant for rat 
neutrophils in vivo and to desensitize the cells to subsequent 
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HNE exposure [27,28]. In our experiments the number of 
monocytes responding to HNE was only slightly lower than 
that for fMLP (78%). Therefore, monocytes appear to be 
more homogenous in their response to HNE. However, occa- 
sional preparations of monocytes also did not show any re- 
sponse to HNE. In contrast o rat pleural neutrophils [25,29], 
human monocytes howed no significant chemotaxis towards 
HOE, Hexanal is ineffective for both cell types [30]. Several 
hydroxyalkenals, including HNE and HOE, inhibit random 
migration of rat neutrophils at concentrations above 10 .-5 
M, an effect which was not due to toxicity [14,25]. In our 
experiments, HNE, HOE and HHE displayed inhibitory ac- 
tivity for monocyte random migration at similar concentra- 
tions. The mechanism by which hydroxyalkenals inhibit cell 
migration is unknown. 
One characteristic of the atherosclerotic lesion is the ab- 
sence of neutrophils and the mechanism by which monocytes 
are selectively attracted into the intima is still a matter of 
intense study. Minimally-modified LDL was found to selec- 
tively promote the adhesion of monocytes to rat and human 
endothelial cells [31] by inducing the expression of a glycopro- 
tein on the surface of endothelial cells [32]. This monocyte- 
specific adhesion molecule has not been fully characterized so 
far, but it is different from E-selectin, VCAM-1 and ICAM-1. 
Furthermore, minimally-modified LDL stimulates endothelial 
cells and smooth muscle cells to express a monocyte-specific 
chemoattractant, MCP-1 [33]. Oxidised LDL stimulates the 
expression of P-selectin by rat endothelial cells [34], facilitat- 
ing leukocyte-endothelium interactions, and lysophosphatidyl 
choline, which was reported to selectively attract monocytes 
[4], stimulates the expression of leukocyte-adhesion molecules 
ICAM-1 and VCAM-1 on rat and human endothelial cells 
[35]. 
Our data suggest that the potent chemoattractant activity of 
HNE may contribute to the attraction of monocytes into 
atherosclerotic lesions by oxidised LDL. As HNE also attracts 
neutrophils, selectivity for monocytes in vivo may be achieved 
by other mechanisms, for example by expression of monocyte- 
specific adhesion molecules on endothelial cells. However, the 
role of aldehydes in foam cell death appears less certain, and 
other components of oxidised LDL are more likely to be 
responsible for cell-killing. 
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